← All stocks

60 DEGREES PHARMACEUTICALS, INC.

SXTP Net buying
CIK 0001946563 #5496 in the set updated 19 Sep 2026
Bought (120 mo)
$255.27K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$255.27K
+$255.27K against sales at will

By person

8 insiders · 28 transactions
0.1×

Geoffrey Dow holds only 0.1 times base salary in stock. $33.26K of shares against $250.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Geoffrey Dow last reported holding, valued at $1.38, the price Common Stock was last bought or sold at on the open market here, on 12 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
DOW GEOFFREY S
President and CEO
$135.96K (11)
+$135.96K
24,131
$33.26K
XU CHERYL
Director
$119.31K (11)
+$119.31K
15,816
$21.80K
Knight Therapeutics Inc entity
Former 10% Owner
1,153,897
$1.59M
+3.9%
MILLER TYRONE
CFO
26,370
$36.35K
Allen Charles W
Director
14,000
$19.30K
+40.0%
TOOVEY STEPHEN
Director
14,000
$19.30K
+40.0%
FIELD PAUL
Director
14,000
$19.30K
+40.0%
Landon Kristen
Chief Operating Officer
4,540
$6.26K

No percentages here. This company's share count has moved by a factor of 2.9 over the window, from 1,472,891 to 4,230,448 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 265,859
History held since 12 Jul 2023